Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 06 2019
Historique:
received: 06 11 2018
accepted: 28 05 2019
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

With the exception of renal cell carcinoma, studies assessing the association between hypertension and other cancers are inconsistent. We conducted a meta-analysis to assess this evidence. We included observational studies investigating the association between any definition of hypertension or systolic and diastolic blood pressure and risk of any cancer, after searching PubMed until November 2017. We calculated summary relative risks (RR) and 95% confidence intervals (CI) using inverse-variance weighted random effects methods. A total of 148 eligible publications were identified out of 39,891 initially screened citations. Considering only evidence from 85 prospective studies, positive associations were observed between hypertension and kidney, colorectal and breast cancer. Positive associations between hypertension and risk of oesophageal adenocarcinoma and squamous cell carcinoma, liver and endometrial cancer were also observed, but the majority of studies did not perform comprehensive multivariable adjustments. Systolic and diastolic blood pressure were positively associated with risk of kidney cancer but not with other cancers. In addition to the previously well-described association between hypertension and risk of kidney cancer, the current meta-analysis suggested that hypertensive individuals may also be at higher risk of colorectal and breast cancer. However, careful interpretation is required as most meta-analyses included relatively small number of studies, several relative risks had weak or moderate magnitude and maybe affected by residual confounding.

Identifiants

pubmed: 31189941
doi: 10.1038/s41598-019-45014-4
pii: 10.1038/s41598-019-45014-4
pmc: PMC6561976
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8565

Références

Ann Oncol. 2007 Mar;18(3):596-600
pubmed: 17158772
Eur Urol. 2012 Mar;61(3):560-70
pubmed: 22119157
Ann Epidemiol. 1997 Oct;7(7):486-9
pubmed: 9349916
BMC Cancer. 2015 Oct 16;15:720
pubmed: 26475132
Ann Chir Gynaecol Suppl. 1994;208:20-4
pubmed: 8092764
Cancer Prev Res (Phila). 2011 Nov;4(11):1873-83
pubmed: 21697276
Cancer Epidemiol. 2012 Apr;36(2):177-82
pubmed: 22000673
Eur Urol. 2015 Jan;67(1):64-70
pubmed: 24568896
Hypertension. 1999 Aug;34(2):320-5
pubmed: 10454461
J Hypertens. 2000 Mar;18(3):249-54
pubmed: 10726709
Br J Cancer. 2008 Dec 2;99(11):1912-5
pubmed: 19034282
Cancer. 2017 Feb 15;123(4):657-665
pubmed: 27861759
Am J Epidemiol. 2009 Dec 1;170(11):1422-32
pubmed: 19875646
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53
pubmed: 19567502
Metabolism. 2011 Oct;60(10):1372-8
pubmed: 21550085
Cancer Causes Control. 1992 Jul;3(4):323-31
pubmed: 1617119
Cancer Causes Control. 2010 Mar;21(3):463-72
pubmed: 19949849
Cancer Causes Control. 2000 Feb;11(2):185-92
pubmed: 10710204
Menopause. 2013 Dec;20(12):1301-9
pubmed: 23571527
Endocr Relat Cancer. 2007 Sep;14(3):755-67
pubmed: 17914105
Urol Clin North Am. 2004 May;31(2):237-47
pubmed: 15123404
Cancer Causes Control. 2005 Nov;16(9):1099-106
pubmed: 16184476
Cancer Epidemiol. 2012 Apr;36(2):141-7
pubmed: 21890443
Br J Cancer. 2005 Apr 11;92(7):1302-6
pubmed: 15812478
Cancer Causes Control. 2002 Apr;13(3):287-93
pubmed: 12020111
Endocrine. 2013 Dec;44(3):634-47
pubmed: 23546613
Br J Cancer. 2003 Oct 6;89(7):1243-7
pubmed: 14520454
Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):327-31
pubmed: 7655326
Asian Pac J Cancer Prev. 2012;13(1):139-46
pubmed: 22502657
Ann Oncol. 2011 Dec;22(12):2687-2692
pubmed: 21415236
J Hum Hypertens. 2005 May;19(5):373-9
pubmed: 15703772
Epidemiology. 2011 Nov;22(6):797-804
pubmed: 21881515
Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):863-73
pubmed: 9367058
Tumour Biol. 2016 Apr;37(4):4721-6
pubmed: 26511973
J Natl Cancer Inst. 1989 Oct 18;81(20):1571-4
pubmed: 2477555
Int J Cancer. 2003 May 10;104(6):669-76
pubmed: 12640672
Cancer Res. 1991 Jan 15;51(2):568-72
pubmed: 1985774
J Hypertens. 2017 Jul;35(7):1333-1344
pubmed: 28157813
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Urol Oncol. 2012 Mar-Apr;30(2):220-4
pubmed: 22385993
Scand J Gastroenterol. 1993 Jun;28(6):475-81
pubmed: 8322022
Circulation. 2016 Mar 15;133(11):1104-14
pubmed: 26976915
J Hypertens. 1998 Jul;16(7):941-7
pubmed: 9794734
Cancer. 2003 Oct 1;98(7):1504-13
pubmed: 14508839
J Hypertens. 2005 Nov;23(11):1997-2004
pubmed: 16208141
Cancer Causes Control. 2015 Dec;26(12):1825-34
pubmed: 26450604
Carcinogenesis. 2010 Nov;31(11):1964-71
pubmed: 20732908
Gynecol Oncol. 2010 Apr;117(1):41-6
pubmed: 20096921
Int J Cancer. 2011 Apr 15;128(8):1890-8
pubmed: 20568111
Dis Colon Rectum. 2017 Nov;60(11):1192-1200
pubmed: 28991084
Methods Mol Biol. 2018;1793:211-230
pubmed: 29876899
Ann Oncol. 2011 Apr;22(4):884-889
pubmed: 20937645
J Epidemiol. 2005 Jun;15 Suppl 2:S168-72
pubmed: 16127229
Int J Cancer. 1997 Jan 27;70(3):265-8
pubmed: 9033625
Nutr Cancer. 2003;46(2):119-24
pubmed: 14690786
World J Surg Oncol. 2015 Aug 07;13:236
pubmed: 26246367
Front Oncol. 2017 Sep 25;7:211
pubmed: 28993797
Epidemiology. 2015 Jan;26(1):59-67
pubmed: 25393631
Am J Epidemiol. 2016 Feb 15;183(4):259-68
pubmed: 26823438
Br J Cancer. 2013 Nov 26;109(11):2924-32
pubmed: 24149173
Am J Med. 2002 Apr 15;112(6):479-86
pubmed: 11959059
Medicine (Baltimore). 2015 Apr;94(16):e753
pubmed: 25906108
Jpn J Cancer Res. 1994 Apr;85(4):346-50
pubmed: 8200846
Int J Obes (Lond). 2008 Feb;32(2):304-14
pubmed: 17878894
J Prev Med Public Health. 2016 May;49(3):143-52
pubmed: 27255073
Sci Rep. 2017 Apr 07;7:44808
pubmed: 28387226
Ann Acad Med Singap. 2013 Mar;42(3):120-4
pubmed: 23604500
Int Braz J Urol. 2012 Nov-Dec;38(6):769-78
pubmed: 23302414
PLoS One. 2015 Jun 01;10(6):e0128891
pubmed: 26030767
J Hypertens. 1998 Jul;16(7):933-40
pubmed: 9794733
Cancer Epidemiol. 2016 Jun;42:9-14
pubmed: 26972225
Am J Epidemiol. 2007 Oct 15;166(8):932-40
pubmed: 17656615
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2391-7
pubmed: 17164361
J Hypertens. 2012 Feb;30(2):290-6
pubmed: 22179083
BMC Cancer. 2014 Feb 18;14:103
pubmed: 24548688
Res Synth Methods. 2010 Apr;1(2):97-111
pubmed: 26061376
Cancer Causes Control. 2013 Jun;24(6):1061-8
pubmed: 23504150
Int J Epidemiol. 1994 Oct;23(5):923-30
pubmed: 7860172
Sci Rep. 2017 Mar 20;7:44877
pubmed: 28317900
J Exp Clin Cancer Res. 2013 Feb 13;32:9
pubmed: 23406686
J Hum Hypertens. 2006 Oct;20(10):727-32
pubmed: 16885996
Am J Epidemiol. 1991 Nov 1;134(9):942-7
pubmed: 1951291
Diabetes Metab. 2015 Dec;41(6):463-9
pubmed: 26037090
Eur J Oncol Nurs. 2009 Apr;13(2):122-7
pubmed: 19332387
Asian Pac J Cancer Prev. 2012;13(11):5829-34
pubmed: 23317264
J Prev Med Public Health. 2013 Nov;46(6):346-52
pubmed: 24349656
Nat Rev Urol. 2010 May;7(5):245-57
pubmed: 20448658
Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):385-91
pubmed: 11927499
Breast Cancer Res Treat. 2012 Aug;134(3):1247-56
pubmed: 22710709
Hepatology. 2011 Aug;54(2):463-71
pubmed: 21538440
BMC Public Health. 2015 Sep 18;15:913
pubmed: 26385727
Cancer Causes Control. 2015 Aug;26(8):1173-80
pubmed: 26081424
Prostate. 2004 Jan 1;58(1):50-6
pubmed: 14673952
Tumori. 2016 Jun 2;2016(3):252-7
pubmed: 26350180
Hypertension. 1996 Sep;28(3):321-4
pubmed: 8794810
Am J Epidemiol. 1994 Nov 1;140(9):792-804
pubmed: 7977290
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
J Endocrinol Invest. 2013 Feb;36(2):132-9
pubmed: 23481613
JAMA Intern Med. 2013 Sep 23;173(17):1629-37
pubmed: 23921840
J Hypertens. 1997 Dec;15(12 Pt 2):1573-7
pubmed: 9488208
Indian J Urol. 2011 Jul;27(3):345-50
pubmed: 22022057
Am J Obstet Gynecol. 1992 Nov;167(5):1317-25
pubmed: 1442985
Sci Rep. 2016 Aug 11;6:31358
pubmed: 27511796
Int J Cancer. 2004 Jan 1;108(1):115-21
pubmed: 14618625
Int J Epidemiol. 1993 Dec;22(6):1000-9
pubmed: 8144280
Br J Cancer. 2011 Oct 25;105(9):1424-9
pubmed: 21915122
Am J Epidemiol. 1992 Jun 1;135(11):1301-9
pubmed: 1626547
BJU Int. 2011 Mar;107(6):929-35
pubmed: 20880183
Urology. 2009 Jul;74(1):185-90
pubmed: 19428088
Br J Cancer. 2006 Mar 13;94(5):752-6
pubmed: 16495922
Prostate Cancer Prostatic Dis. 2013 Jun;16(2):181-6
pubmed: 23399780
Hypertension. 2014 May;63(5):934-41
pubmed: 24637660
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Circulation. 2014 Jan 21;129(3):e28-e292
pubmed: 24352519
Prostate. 1989;14(2):117-22
pubmed: 2710690
Cancer Causes Control. 2009 Dec;20(10):1811-20
pubmed: 19533392
J Natl Cancer Inst. 1986 Jul;77(1):63-70
pubmed: 3459926
Am J Epidemiol. 1989 Mar;129(3):511-7
pubmed: 2916544
J Urol. 2013 Nov;190(5):1657-61
pubmed: 23665301
N Engl J Med. 2000 Nov 2;343(18):1305-11
pubmed: 11058675
Cancer. 2007 Mar 1;109(5):875-81
pubmed: 17265528
Oncol Lett. 2017 Nov;14(5):5059-5068
pubmed: 29098020
Br J Cancer. 2013 Jan 15;108(1):222-8
pubmed: 23169288
J Clin Gastroenterol. 2013 Jan;47(1):33-44
pubmed: 23090040
Int J Epidemiol. 2007 Oct;36(5):951-7
pubmed: 17921195
J Epidemiol Community Health. 2011 Nov;65(11):1053-8
pubmed: 21389009
J Clin Hypertens (Greenwich). 2014 Aug;16(8):551-3
pubmed: 25040331
Cancer Res. 1997 Nov 15;57(22):5077-85
pubmed: 9371506
Asian Pac J Cancer Prev. 2014 Jan;14(11):6523-8
pubmed: 24377561
J Hypertens. 2002 Apr;20(4):617-22
pubmed: 11910295
Cancer Causes Control. 2011 Feb;22(2):311-8
pubmed: 21116843
Cancer Causes Control. 1993 Nov;4(6):555-8
pubmed: 8280833
Ann Epidemiol. 2011 Nov;21(11):835-41
pubmed: 21982487
Br J Cancer. 2007 Jul 2;97(1):112-4
pubmed: 17519895
BMJ. 2011 Feb 10;342:d549
pubmed: 21310794
Eur J Cancer Prev. 2009 Jun;18(3):240-7
pubmed: 19491612
Eur J Cancer. 2010 Jul;46(10):1866-72
pubmed: 20395126
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):261-7
pubmed: 25587111
Cancer. 2006 Jul 1;107(1):28-36
pubmed: 16721800
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45
pubmed: 20615887
Endocrine. 2014 Feb;45(1):28-36
pubmed: 23640372
Eur J Cancer. 1990;26(7):781-5
pubmed: 2145895
Int J Oncol. 1996 Mar;8(3):439-44
pubmed: 21544380
Hypertension. 2012 Apr;59(4):802-10
pubmed: 22353615
Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2384-95
pubmed: 21921255
PLoS One. 2013;8(2):e57475
pubmed: 23468995
Curr Drug Saf. 2007 May;2(2):125-33
pubmed: 18690958
Br J Cancer. 1998 May;77(9):1508-13
pubmed: 9652770
Eur J Cancer Prev. 2012 Jul;21(4):326-32
pubmed: 22044849
Am J Med. 2017 Jun;130(6):746.e1-746.e7
pubmed: 28109969
Ann Epidemiol. 2001 Nov;11(8):534-42
pubmed: 11709272
Nutr Metab Cardiovasc Dis. 2010 Jan;20(1):41-8
pubmed: 19361966
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1448-56
pubmed: 19383893
Kidney Int. 2005 Feb;67(2):647-52
pubmed: 15673312
Cancer. 2006 Jun 1;106(11):2376-81
pubmed: 16639730
Cancer Causes Control. 2010 Oct;21(10):1615-24
pubmed: 20526803
Cancer. 2012 Dec 15;118(24):6199-206
pubmed: 23090855
J Clin Gastroenterol. 2014 Feb;48(2):172-7
pubmed: 24402120
Int J Cancer. 1995 Oct 9;63(2):216-21
pubmed: 7591207
J Epidemiol. 2005 Jun;15 Suppl 2:S203-11
pubmed: 16127235
Int J Cancer. 2017 Dec 15;141(12):2450-2461
pubmed: 28842914
Am J Epidemiol. 1999 Mar 15;149(6):521-30
pubmed: 10084241
Lancet. 1975 May 10;1(7915):1051-6
pubmed: 48728
Cancer Causes Control. 1993 Mar;4(2):101-10
pubmed: 8481488
Am J Epidemiol. 1997 Apr 1;145(7):607-13
pubmed: 9098177
Am J Epidemiol. 2008 Feb 15;167(4):438-46
pubmed: 18048375
Cancer Causes Control. 2010 Jan;21(1):117-25
pubmed: 19816779
PLoS Med. 2019 Jan 3;16(1):e1002724
pubmed: 30605491
Am J Epidemiol. 2006 Dec 1;164(11):1094-102
pubmed: 16968859
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Asian Pac J Cancer Prev. 2012;13(6):2879-86
pubmed: 22938477
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):359-64
pubmed: 18268120
Cancer Causes Control. 2012 Aug;23(8):1241-51
pubmed: 22661101
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):673-5
pubmed: 19190162
PLoS One. 2014 Feb 21;9(2):e89368
pubmed: 24586723
Acta Oncol. 1988;27(1):31-7
pubmed: 3365352
Int J Epidemiol. 1990 Dec;19(4):832-8
pubmed: 2084009
Int J Epidemiol. 1999 Oct;28(5):816-23
pubmed: 10597976
Cancer Causes Control. 2004 Aug;15(6):535-41
pubmed: 15280632
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):937-41
pubmed: 11535544
Med Hypotheses. 2006;66(4):732-5
pubmed: 16364563
Int J Cancer. 2010 Oct 1;127(7):1660-8
pubmed: 20087861
Am J Epidemiol. 2006 Oct 1;164(7):652-64
pubmed: 16877536
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
Am J Epidemiol. 2006 Oct 15;164(8):769-74
pubmed: 16952929
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Aristeidis Seretis (A)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Sofia Cividini (S)

Independent Researcher in Biostatistics, Como, Italy.

Georgios Markozannes (G)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

Xanthippi Tseretopoulou (X)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

David S Lopez (DS)

The University of Texas School of Public Health, Houston, TX, USA.

Evangelia E Ntzani (EE)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Center for Evidence-Based Medicine, Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, RI, USA.

Konstantinos K Tsilidis (KK)

Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. k.tsilidis@imperial.ac.uk.
Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK. k.tsilidis@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH